These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 5509491)

  • 1. Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients.
    Ananth JV; Horodesky S; Lehmann HE; Ban TA
    Laval Med; 1970 Sep; 41(7):934-8. PubMed ID: 5509491
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 3. A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital.
    Lehmann HE; Ban TA; Saxena BM
    Laval Med; 1970 Sep; 41(7):909-16. PubMed ID: 5509489
    [No Abstract]   [Full Text] [Related]  

  • 4. A survey of extrapyramidal manifestations in patients attending an after care clinic of a psychiatric hospital.
    Guttman H; Lehmann HE; Ban TA
    Laval Med; 1970 Apr; 41(4):449-55. PubMed ID: 5515661
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-acting antiparkinson agents. I. Pilot study on benzetimide (342 cases)].
    Korn M; Pinchard A; Breulet M; Goffioul F; Bobon J
    Acta Psychiatr Belg; 1971 Mar; 71(2):65-75. PubMed ID: 5560276
    [No Abstract]   [Full Text] [Related]  

  • 6. [Extrapyramidal accidents in outpatient therapy].
    Rouleau Y
    Laval Med; 1970 Sep; 41(7):906-8. PubMed ID: 5509488
    [No Abstract]   [Full Text] [Related]  

  • 7. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa; Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies with antiparkinsonian drugs with chronic psychiatric patients.
    Roy P; St-Jean A; Ban T; Noe W
    Int J Neuropsychiatry; 1966 Feb; 2(1):65-9. PubMed ID: 5907816
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-acting, antipsychotic agents and extrapyramidal side effects.
    Simpson GM
    Dis Nerv Syst; 1970 Sep; 31():Suppl:12-4. PubMed ID: 5476354
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extrapyramidal syndrome and spondyloarthritis ankylopoietica in a schizophrenic patient].
    Lipiński B
    Psychiatr Pol; 1970; 4(2):211-4. PubMed ID: 5427765
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenothiazine toxicity in paediatric practice with three case reports.
    Bajpai PC; Sethi VK; Pathak AK; Tripathi TK
    Indian Pediatr; 1969 Jul; 6(7):470-5. PubMed ID: 5345025
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complex persisting dyskinesia, secondary to neuroleptic therapy].
    Castaigne P; Lapresle J; Chain F
    Rev Neurol (Paris); 1969 Mar; 120(3):215-9. PubMed ID: 5343991
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transitory exacerbations arising during the course of neuroleptic therapy].
    Gurovich IIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):919-25. PubMed ID: 5471621
    [No Abstract]   [Full Text] [Related]  

  • 15. Butaclamol hydrochloride (AY-23,028): an early evaluation in severely ill schizophrenics.
    Mielke DH; Gallant DM; Oelsner T; Kessler CM; Tomlinson WK; Cohen GH
    Dis Nerv Syst; 1975 Jan; 36(1):7-8. PubMed ID: 1089058
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Nardini M; Fanali A; Sorgonà F; Vergnano M; Fieschi G
    Minerva Med; 1971 Oct; 62(82):4020-3. PubMed ID: 5125070
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S
    Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253
    [No Abstract]   [Full Text] [Related]  

  • 18. [Orolingual dyskinesia caused by prolonged neuroplegic therapy].
    Fenyvesi T
    Orv Hetil; 1968 Sep; 109(39):2149-52. PubMed ID: 5716904
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A; Nardini M; Sorgona F
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract]   [Full Text] [Related]  

  • 20. [Late irreversible extrapyramidal syndrome following neuroleptic use].
    Boucebci M
    Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.